ICF Mercantile

Technical Fiber Solutions for Medical Textile Applications

MEDI-FILS, Thread for Life, a New Supply Chain Concept

for Medical Devices Now Approved and Available

What is MEDI-FILS

MEDI-FILS is a continuous filament polyester (PET) yarn created to satisfy the requirements for medical textile implantable applications.

About ICF Mercantile

ICF is dedicated to the research, development, and manufacture of yarn for medical devices. Our production is based on customers specific requirements. We offer low minimum quantities, custom product requirements, traceability, equipment validation, and a pristine processing facility. We are ISO 9001:2015 and ISO 13485:2016 certified.

ICF’s commitment:

We are driven by our customer’s specific requirements. We do not limit our customer’s development needs.


Our approach creates a positive environment during the R&D phase through production and qualification. We never say, “off the shelf, take it or leave it”.


We deliver products based on our customer’s requirements.

ICF Capability

Our production line capabilities are designed for flexibility, which reduces our MOQ and allows for on-time delivery, producing products to our customer’s specifications.


We have a full scale industrial manufacturing facility set up to provide low MOQ’s. We are able to offer repeatability of the product from one production lot to the next.


ICF has complete control of its supply chain, from extrusion to final product. All production is manufactured in one location (Warren, NJ) U.S.A.


ICF has its own laboratory facilities to perform all tests needed for both research and development of product and specifications, as well as to provide in-process control. Our products are certified by COA’s generated in our lab.

Contact us


ICF Mercantile LLC

150 Mt Bethel Rd,

Warren,

NJ 07059


Phone : (908) 293-8280

Fax : (201) 482-8037

Web : www.icfmercantile.com:

Email : sales@icfmercantile.com

Go to article: Home | The triumph of telemedicineGo to article: In This IssueGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: ContentsGo to article: ElectroCraft Company InsightGo to article: ElectroCraftGo to article: NewsGo to article: Coronavirus Executive BriefingGo to article: Helbling Go to article: Phosphorus and BioIQ announce partnership for at-home Covid-19 testing kitsGo to article: Roche’s Covid-19 tests could be enough to offset losses during lockdownGo to article: CRISPR biotechnology set to disrupt Covid-19 testing marketGo to article: Resumption of elective surgeries in the US to be short-livedGo to article: Abbott’s ID NOW Covid-19 test under questionGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: The medical industry briefingGo to article: Mus musculus: how nanofluidic drug delivery could counter muscle loss in spaceGo to article: Coding in medtech: setting standards for the digital ageGo to article: SartoriusGo to article: Will digital mental health solutions thrive after Covid-19?Go to article: South Korea: the rise of a new medtech giant? Go to article: ICF MercantileGo to article: Is there a bright future for telemedicine in a post-Covid world?Go to article: PSN LabsGo to article: Q&A: discussing cancer blood testing tech with VolitionGo to article: dokspotGo to article: What does the MDR delay mean for the European medtech sector?Go to article: Covid-19 immunity passports: how to protect health dataGo to article: The key list powered by GlobalDataGo to article: Deals in brief powered by GlobalDataGo to article: TS Quality & EngineeringGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2 ) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next Issue